According to HBM Healthcare Investments's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -18.0968. At the end of 2016 the company had a P/E ratio of -7.63.
Year | P/E ratio | Change |
---|---|---|
2016 | -7.63 | -220.03% |
2015 | 6.36 | 179.31% |
2014 | 2.28 | 28.43% |
2013 | 1.77 | -92.78% |
2012 | 24.6 | -299.72% |
2011 | -12.3 | 166.96% |
2010 | -4.60 |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.